Loading…
METTL14‑mediated RNA methylation in digestive system tumors
N6-methyladenosine (m6A) RNA methylation is one of the most common post-transcriptional modification mechanism in eukaryotes. m6A is involved in almost all stages of the mRNA life cycle, specifically regulating its stability, splicing, export and translation. Methyltransferase-like 14 (METTL14) is a...
Saved in:
Published in: | International journal of molecular medicine 2023-09, Vol.52 (3), p.1, Article 86 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c486t-f1775503b8f7f038dea87ea8a5bfc01e5183506382cc9e979518514d1857d5873 |
---|---|
cites | cdi_FETCH-LOGICAL-c486t-f1775503b8f7f038dea87ea8a5bfc01e5183506382cc9e979518514d1857d5873 |
container_end_page | |
container_issue | 3 |
container_start_page | 1 |
container_title | International journal of molecular medicine |
container_volume | 52 |
creator | Hu, Jiexuan Lin, Haishan Wang, Cong Su, Qiang Cao, Bangwei |
description | N6-methyladenosine (m6A) RNA methylation is one of the most common post-transcriptional modification mechanism in eukaryotes. m6A is involved in almost all stages of the mRNA life cycle, specifically regulating its stability, splicing, export and translation. Methyltransferase-like 14 (METTL14) is a particularly important m6A methylation 'writer' that can recognize RNA substrates. METTL14 has been documented to improve the activity and catalytic efficiency of METTL3. However, as individual proteins they can also regulate different biological processes. Malignancies in the digestive system are some of the most common malignancies found in humans, which are typically associated with poor prognoses with limited clinical solutions. METTL14-mediated methylation has been implicated in both the potentiation and inhibition of digestive system tumor growth, cell invasion and metastasis, in addition to drug resistance. In the present review, the research progress and regulatory mechanisms of METTL14-mediated methylation in digestive system malignancies were summarized. In addition, future research directions and the potential for its clinical application were examined. |
doi_str_mv | 10.3892/ijmm.2023.5289 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10555478</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A764558079</galeid><sourcerecordid>A764558079</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-f1775503b8f7f038dea87ea8a5bfc01e5183506382cc9e979518514d1857d5873</originalsourceid><addsrcrecordid>eNptUctKAzEUDaJYrW5dD7iemuckWYiUUh9QFaSCu5BmMm1KM6mTaaE7f8Ff9EtMsShCueTecHLu4YQDwAWCPSIkvnJz73sYYtJjWMgDcIK4RDmm9O0w3RHkOeGs6IDTGOcQYkalOAadhBHJcXECrh-H4_EI0a-PT29Lp1tbZi9P_czbdrZZ6NaFOnN1Vrqpja1b2yxuYmt91q58aOIZOKr0Itrz3eyC19vheHCfj57vHgb9UW6oKNq8QpwzBslEVLyCRJRWC56OZpPKQGQZEoTBgghsjLSSywQwRMvUeckEJ11w86O7XE2STWPrttELtWyc181GBe3U_5fazdQ0rBWCjDHKRVK43Ck04X2V_qLmYdXUybTCghVI4oLSP9ZUL6xydRWSmvEuGtXnBWVMQC4Tq7eHlaq03plQ28olfN-CaUKMja1-nSOotjGqbYxqG6Paxki-Aa_sjeg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2856192644</pqid></control><display><type>article</type><title>METTL14‑mediated RNA methylation in digestive system tumors</title><source>Alma/SFX Local Collection</source><creator>Hu, Jiexuan ; Lin, Haishan ; Wang, Cong ; Su, Qiang ; Cao, Bangwei</creator><creatorcontrib>Hu, Jiexuan ; Lin, Haishan ; Wang, Cong ; Su, Qiang ; Cao, Bangwei</creatorcontrib><description>N6-methyladenosine (m6A) RNA methylation is one of the most common post-transcriptional modification mechanism in eukaryotes. m6A is involved in almost all stages of the mRNA life cycle, specifically regulating its stability, splicing, export and translation. Methyltransferase-like 14 (METTL14) is a particularly important m6A methylation 'writer' that can recognize RNA substrates. METTL14 has been documented to improve the activity and catalytic efficiency of METTL3. However, as individual proteins they can also regulate different biological processes. Malignancies in the digestive system are some of the most common malignancies found in humans, which are typically associated with poor prognoses with limited clinical solutions. METTL14-mediated methylation has been implicated in both the potentiation and inhibition of digestive system tumor growth, cell invasion and metastasis, in addition to drug resistance. In the present review, the research progress and regulatory mechanisms of METTL14-mediated methylation in digestive system malignancies were summarized. In addition, future research directions and the potential for its clinical application were examined.</description><identifier>ISSN: 1107-3756</identifier><identifier>EISSN: 1791-244X</identifier><identifier>DOI: 10.3892/ijmm.2023.5289</identifier><identifier>PMID: 37539726</identifier><language>eng</language><publisher>Athens: Spandidos Publications</publisher><subject>Adenosine ; Cell growth ; Digestive system ; DNA methylation ; Epigenetics ; Gastric cancer ; Gastrointestinal diseases ; Genetic transcription ; Liver cancer ; Medical prognosis ; Metastasis ; Methylation ; Methyltransferases ; MicroRNAs ; Phosphorylation ; Prognosis ; Proteins ; Regulation ; RNA ; Roles ; Tumors</subject><ispartof>International journal of molecular medicine, 2023-09, Vol.52 (3), p.1, Article 86</ispartof><rights>COPYRIGHT 2023 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2023</rights><rights>Copyright: © Hu et al. 2023</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c486t-f1775503b8f7f038dea87ea8a5bfc01e5183506382cc9e979518514d1857d5873</citedby><cites>FETCH-LOGICAL-c486t-f1775503b8f7f038dea87ea8a5bfc01e5183506382cc9e979518514d1857d5873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids></links><search><creatorcontrib>Hu, Jiexuan</creatorcontrib><creatorcontrib>Lin, Haishan</creatorcontrib><creatorcontrib>Wang, Cong</creatorcontrib><creatorcontrib>Su, Qiang</creatorcontrib><creatorcontrib>Cao, Bangwei</creatorcontrib><title>METTL14‑mediated RNA methylation in digestive system tumors</title><title>International journal of molecular medicine</title><description>N6-methyladenosine (m6A) RNA methylation is one of the most common post-transcriptional modification mechanism in eukaryotes. m6A is involved in almost all stages of the mRNA life cycle, specifically regulating its stability, splicing, export and translation. Methyltransferase-like 14 (METTL14) is a particularly important m6A methylation 'writer' that can recognize RNA substrates. METTL14 has been documented to improve the activity and catalytic efficiency of METTL3. However, as individual proteins they can also regulate different biological processes. Malignancies in the digestive system are some of the most common malignancies found in humans, which are typically associated with poor prognoses with limited clinical solutions. METTL14-mediated methylation has been implicated in both the potentiation and inhibition of digestive system tumor growth, cell invasion and metastasis, in addition to drug resistance. In the present review, the research progress and regulatory mechanisms of METTL14-mediated methylation in digestive system malignancies were summarized. In addition, future research directions and the potential for its clinical application were examined.</description><subject>Adenosine</subject><subject>Cell growth</subject><subject>Digestive system</subject><subject>DNA methylation</subject><subject>Epigenetics</subject><subject>Gastric cancer</subject><subject>Gastrointestinal diseases</subject><subject>Genetic transcription</subject><subject>Liver cancer</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Methylation</subject><subject>Methyltransferases</subject><subject>MicroRNAs</subject><subject>Phosphorylation</subject><subject>Prognosis</subject><subject>Proteins</subject><subject>Regulation</subject><subject>RNA</subject><subject>Roles</subject><subject>Tumors</subject><issn>1107-3756</issn><issn>1791-244X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNptUctKAzEUDaJYrW5dD7iemuckWYiUUh9QFaSCu5BmMm1KM6mTaaE7f8Ff9EtMsShCueTecHLu4YQDwAWCPSIkvnJz73sYYtJjWMgDcIK4RDmm9O0w3RHkOeGs6IDTGOcQYkalOAadhBHJcXECrh-H4_EI0a-PT29Lp1tbZi9P_czbdrZZ6NaFOnN1Vrqpja1b2yxuYmt91q58aOIZOKr0Itrz3eyC19vheHCfj57vHgb9UW6oKNq8QpwzBslEVLyCRJRWC56OZpPKQGQZEoTBgghsjLSSywQwRMvUeckEJ11w86O7XE2STWPrttELtWyc181GBe3U_5fazdQ0rBWCjDHKRVK43Ck04X2V_qLmYdXUybTCghVI4oLSP9ZUL6xydRWSmvEuGtXnBWVMQC4Tq7eHlaq03plQ28olfN-CaUKMja1-nSOotjGqbYxqG6Paxki-Aa_sjeg</recordid><startdate>20230901</startdate><enddate>20230901</enddate><creator>Hu, Jiexuan</creator><creator>Lin, Haishan</creator><creator>Wang, Cong</creator><creator>Su, Qiang</creator><creator>Cao, Bangwei</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20230901</creationdate><title>METTL14‑mediated RNA methylation in digestive system tumors</title><author>Hu, Jiexuan ; Lin, Haishan ; Wang, Cong ; Su, Qiang ; Cao, Bangwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-f1775503b8f7f038dea87ea8a5bfc01e5183506382cc9e979518514d1857d5873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adenosine</topic><topic>Cell growth</topic><topic>Digestive system</topic><topic>DNA methylation</topic><topic>Epigenetics</topic><topic>Gastric cancer</topic><topic>Gastrointestinal diseases</topic><topic>Genetic transcription</topic><topic>Liver cancer</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Methylation</topic><topic>Methyltransferases</topic><topic>MicroRNAs</topic><topic>Phosphorylation</topic><topic>Prognosis</topic><topic>Proteins</topic><topic>Regulation</topic><topic>RNA</topic><topic>Roles</topic><topic>Tumors</topic><toplevel>online_resources</toplevel><creatorcontrib>Hu, Jiexuan</creatorcontrib><creatorcontrib>Lin, Haishan</creatorcontrib><creatorcontrib>Wang, Cong</creatorcontrib><creatorcontrib>Su, Qiang</creatorcontrib><creatorcontrib>Cao, Bangwei</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hu, Jiexuan</au><au>Lin, Haishan</au><au>Wang, Cong</au><au>Su, Qiang</au><au>Cao, Bangwei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>METTL14‑mediated RNA methylation in digestive system tumors</atitle><jtitle>International journal of molecular medicine</jtitle><date>2023-09-01</date><risdate>2023</risdate><volume>52</volume><issue>3</issue><spage>1</spage><pages>1-</pages><artnum>86</artnum><issn>1107-3756</issn><eissn>1791-244X</eissn><abstract>N6-methyladenosine (m6A) RNA methylation is one of the most common post-transcriptional modification mechanism in eukaryotes. m6A is involved in almost all stages of the mRNA life cycle, specifically regulating its stability, splicing, export and translation. Methyltransferase-like 14 (METTL14) is a particularly important m6A methylation 'writer' that can recognize RNA substrates. METTL14 has been documented to improve the activity and catalytic efficiency of METTL3. However, as individual proteins they can also regulate different biological processes. Malignancies in the digestive system are some of the most common malignancies found in humans, which are typically associated with poor prognoses with limited clinical solutions. METTL14-mediated methylation has been implicated in both the potentiation and inhibition of digestive system tumor growth, cell invasion and metastasis, in addition to drug resistance. In the present review, the research progress and regulatory mechanisms of METTL14-mediated methylation in digestive system malignancies were summarized. In addition, future research directions and the potential for its clinical application were examined.</abstract><cop>Athens</cop><pub>Spandidos Publications</pub><pmid>37539726</pmid><doi>10.3892/ijmm.2023.5289</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1107-3756 |
ispartof | International journal of molecular medicine, 2023-09, Vol.52 (3), p.1, Article 86 |
issn | 1107-3756 1791-244X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10555478 |
source | Alma/SFX Local Collection |
subjects | Adenosine Cell growth Digestive system DNA methylation Epigenetics Gastric cancer Gastrointestinal diseases Genetic transcription Liver cancer Medical prognosis Metastasis Methylation Methyltransferases MicroRNAs Phosphorylation Prognosis Proteins Regulation RNA Roles Tumors |
title | METTL14‑mediated RNA methylation in digestive system tumors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A40%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=METTL14%E2%80%91mediated%20RNA%20methylation%20in%20digestive%20system%20tumors&rft.jtitle=International%20journal%20of%20molecular%20medicine&rft.au=Hu,%20Jiexuan&rft.date=2023-09-01&rft.volume=52&rft.issue=3&rft.spage=1&rft.pages=1-&rft.artnum=86&rft.issn=1107-3756&rft.eissn=1791-244X&rft_id=info:doi/10.3892/ijmm.2023.5289&rft_dat=%3Cgale_pubme%3EA764558079%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c486t-f1775503b8f7f038dea87ea8a5bfc01e5183506382cc9e979518514d1857d5873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2856192644&rft_id=info:pmid/37539726&rft_galeid=A764558079&rfr_iscdi=true |